Over the last decade, the development of new drug delivery methods and devices for dry powder inhalation, needle-free intradermal powder injection or sustained parenteral drug delivery has led to an increasing demand for powder formulations incorporating an active pharmaceutical ingredient (API).
Sorry, this page is available to members only.
If you have not registered with us yet, why not
register today for FREE and receive exclusive online access. Interested in receiving European Pharmaceutical Review in print? Subscribe today and guarantee the next six issues delivered direct to your desk, plus gain exclusive access online.
